Aceso Life Science Group Limited (0474.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 698.02M |
| Enterprise Value | 1.72B |
| P/E Ratio | -2.62 |
| PEG Ratio | 0.17 |
| Price/Sales Ratio | 8 |
| Price/Book Ratio | 2.96 |
| Enterprise/Revenue | 14.28 |
| Enterprise/EBITDA | -11.28 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | September 30, 2025 |
Profitability
| Profit Margin | -2.24 |
| Operating Margin | -0.32 |
AD
Management Effectiveness
| Return On Assets | -0.22 |
| Return On Equity | -1.94 |
Income Statement
| Revenue | -68M |
| Revenue/Share | 0.02 |
| Gross Profit | -68M |
| EBITDA | 0 |
| Net Income | 338M |
| Diluted EPS | -0.06 |
Balance Sheet
| Total Cash | 330M |
| Total Cash/Share | 0.05 |
| Total Debt | 1.23B |
| Total Debt/Equity | 3.31 |
| Current Ratio | 3.2 |
| Book Value Per Share | 0.05 |
Price History
| 52-Week Change | 614.29 |
| 52-Week High | 0.16 |
| 52-Week Low | 0.02 |
| Moving Average 50 Days | 0.12 |
| Moving Average 200 Days | 0.12 |
Statistics
| Average Volume | 4.81M |
| Shares Outstanding | 8.86B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 7:6 |
| Last Split Date | July 12, 2017 |
AD
